Doctor profile · Federal record
Dr. MELISSA STUDEBAKER, ARNP-C
Adult Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · MELBOURNE, FL
- NPI 1821230855
- Accepts Medicare
- 18 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2290 W EAU GALLIE BLVD, SUITE 202
MELBOURNE, FL 329353133
(321) 254-4776
fax (321) 254-4840
Credentials & registration
- NPI registered
- April 2009 — 17 yrs on file
- Profile last updated
- March 12, 2015
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Florida #2513912
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821230855. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,605
Distinct HCPCS
10
Medicare allowed
$38,930
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 15,000 | 16 | $1 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 196 | 16 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 78 | 66 | $105 | |
96375 |
Injection of additional new drug or substance into vein | 56 | 24 | $13 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 49 | 38 | $52 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 47 | 35 | $105 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 46 | 42 | $71 | |
96372 |
Injection of drug or substance under skin or into muscle | 41 | 32 | $12 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | 15 | $56 | |
36591 |
Collection of blood sample from implanted device | 22 | 14 | $25 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 438. This provider delivers 36× the peer median.Open Payments
Industry payments received
All-time total
$2,731
Transactions
71
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $218.28 | |
| PFIZER INC. | 9 | $208.51 | |
| Merck Sharp & Dohme LLC | 9 | $193.51 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $181.98 | |
| Incyte Corporation | 4 | $173.41 | |
| Adaptive Biotechnologies Corporation | 2 | $146.09 | |
| Astellas Pharma US Inc | 4 | $144.13 | |
| Janssen Biotech, Inc. | 4 | $116.83 | |
| Novartis Pharmaceuticals Corporation | 6 | $115.18 | |
| Eisai Inc. | 4 | $102.14 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93.90 | |
| SEAGEN INC. | 1 | $74.99 | |
| Gilead Sciences, Inc. | 3 | $74.26 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $73.69 | |
| TAIHO ONCOLOGY, INC. | 3 | $70.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
521
Patients
178
Total drug cost
$520,163
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 98 | 35 | $2,902 |
| Ondansetron Odt (Ondansetron) | Brand | 49 | 37 | $859 |
| Alprazolam | Generic | 48 | 14 | $416 |
| Eliquis (Apixaban) | Brand | 40 | 0 | $28,099 |
| Hydroxyurea | Generic | 40 | 15 | $1,614 |
| Prednisone | Generic | 39 | 21 | $184 |
| Dexamethasone | Generic | 27 | 17 | $592 |
| Nitrofurantoin Mono-Macro (Nitrofurantoin Monohyd/M-Cryst) | Brand | 27 | 14 | $840 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 26 | 0 | $463,921 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 25 | 14 | $599 |